Literature DB >> 31892599

Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence.

Toru Aoyama1, Keisuke Kazama2, Yosuke Atsumi2, Hiroshi Tamagawa2, Ayaka Tamagawa2, Keisuke Komori2, Daisuke Machida2, Yukio Maezawa2, Kazuki Kano2, Kentaro Hara2, Masaaki Murakawa2, Masakatsu Numata2, Takashi Oshima2, Norio Yukawa2, Munetaka Masuda2, Yasushi Rino2.   

Abstract

BACKGROUND: We investigated the clinical influence of anastomotic leak (AL) on esophageal cancer survival and recurrence after curative surgery. PATIENTS AND METHODS: This study included 122 patients who underwent curative surgery for esophageal cancer between 2008 and 2018. The patients were classified into those with AL and those without. The risk factors for overall (OS) and recurrence-free (RFS) survival were identified.
RESULTS: AL was found in 44 out of the 122 patients (36.1%). The respective OS rates at 3 and 5 years after surgery were 43.9% and 40.2% in the AL group and 63.9% and 53.2% in the non-AL group, which were significantly different (p=0.0049). In contrast, the respective RFS rates at 3 and 5 years after surgery were 44.8% and 29.8%, and 44.9% and 42.4%, which were not significantly different (p=0.2306). A multivariate analysis showed that AL was a significant independent risk factor for both poorer OS and RFS in patients who underwent curative surgery for esophageal cancer.
CONCLUSION: To improve survival of patients with esophageal cancer, the surgical procedure, perioperative care and surgical strategy must be carefully planned in order to prevent AL. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Esophageal cancer; anastomosis leak; overall survival; recurrence

Mesh:

Year:  2020        PMID: 31892599     DOI: 10.21873/anticanres.13972

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.

Authors:  Toru Aoyama; Miwa Ju; Keisuke Komori; Hiroshi Tamagawa; Ayako Tamagawa; Atsushi Onodera; Junya Morita; Itaru Hashimoto; Tetsushi Ishiguro; Kazuya Endo; Haruhiko Cho; Shizuνe Onuma; Momoko Fukuda; Takashi Oshima; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  The Impact of Perioperative Fluid Balance on Postoperative Complications after Esophagectomy for Esophageal Cancer.

Authors:  Yuto Kubo; Koji Tanaka; Makoto Yamasaki; Kotaro Yamashita; Tomoki Makino; Takuro Saito; Kazuyoshi Yamamoto; Tsuyoshi Takahashi; Yukinori Kurokawa; Masaaki Motoori; Yutaka Kimura; Kiyokazu Nakajima; Hidetoshi Eguchi; Yuichiro Doki
Journal:  J Clin Med       Date:  2022-06-05       Impact factor: 4.964

3.  The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.

Authors:  Toru Aoyama; Yosuke Atsumi; Shinnosuke Kawahara; Hiroshi Tamagawa; Ayako Tamagawa; Yukihiro Ozawa; Yukio Maezawa; Kazuki Kano; Masaaki Murakawa; Keisuke Kazama; Kenki Segami; Kentaro Hara; Masakatsu Numata; Takashi Oshima; Norio Yukawa; Munetaka Masuda; Yasushi Rino
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Utility of feeding jejunostomy in patients with esophageal cancer undergoing esophagectomy with a high risk of anastomotic leakage.

Authors:  Weitao Zhuang; Hansheng Wu; Huiling Liu; Shujie Huang; Yinghong Wu; Cheng Deng; Dan Tian; Zihao Zhou; Ruiqing Shi; Gang Chen; Guillaume Piessen; Puja G Khaitan; Kazuo Koyanagi; Soji Ozawa; Guibin Qiao
Journal:  J Gastrointest Oncol       Date:  2021-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.